SARS CoV-2 variant B.1.617.1 is highly pathogenic in hamsters than B.1 variant
Pragya D. Yadav, Balram Bhargava(Indian Council of Medical Research), Varsha Potdar(ICMR-National Institute of Virology), Deepak Suryavanshi(ICMR-National Institute of Virology), Dimpal A. Nyayanit(ICMR-National Institute of Virology), Chandrashekhar Mote(Krantisinh Nana Patil College of Veterinary Science), Sreelekshmy Mohandas(ICMR-National Institute of Virology), Manoj Kadam(ICMR-National Institute of Virology), Samiran Panda(Indian Council of Medical Research), Deepak Y. Patil(ICMR-National Institute of Virology), Priya Abraham(ICMR-National Institute of Virology), Sanjay Kumar(Command Hospital), Anita M. Shete(ICMR-National Institute of Virology), Abhimanyu Kumar(ICMR-National Institute of Virology), Nivedita Gupta(Indian Council of Medical Research), Gajanan Sapkal(ICMR-National Institute of Virology)
Cited by 60
Related Papers
SARS-CoV-2 Spike Mutations, L452R, T478K, E484Q and P681R, in the Second Wave of COVID-19 in Maharashtra, India
|Microorganisms|2021|658
Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial
|The Lancet|2021|361
Convergent evolution of SARS-CoV-2 spike mutations, L452R, E484Q and P681R, in the second wave of COVID-19 in Maharashtra, India
|bioRxiv (Cold Spring Harbor Laboratory)|2021|268
Prevalence of SARS-CoV-2 infection in India
|The Indian Journal of Medical Research|2020|225